We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
GenoLogics and Illumina Sign Deal
News

GenoLogics and Illumina Sign Deal

GenoLogics and Illumina Sign Deal
News

GenoLogics and Illumina Sign Deal

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "GenoLogics and Illumina Sign Deal"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

GenoLogics, a provider of laboratory information management system (LIMS) software specifically designed for complex genomics labs, announced it has signed a worldwide co-selling agreement with Illumina,  a leader in next-generation sequencing (NGS) instruments. Under terms of the deal, Illumina will market a version of the Geneus LIMS that is pre-configured for Illumina’s NGS instruments and TruSeq sample preparation kits.

The pre-configured Geneus LIMS software will enable Illumina’s NGS customers to accelerate implementations, track library preparations and instrument runs, and prepare basic reports in a matter of weeks, rather than months. Illumina sells its HiSeq and Genome Analyzer sequencing platforms and TruSeq sample preparation kits to genomics labs in academic institutions and commercial companies worldwide.

“We are pleased to announce this strategic agreement with our partner Illumina and we look forward to serving our joint customers as they initiate their next-generation sequencing research,” said GenoLogics Chief Executive Officer Michael Ball.  “This agreement follows an earlier preferred partner agreement that has allowed us to work closely with Illumina on LIMS software that is complementary to their hardware and sample prep kits. This enables next-generation sequencing labs to deploy instrumentation and data management solutions simultaneously.”

Driven by an increase in sequencing time and a decrease in cost, the NGS market is expected to more than double, from $600 million in 2009 to $1.5 billion in 2014 (Scientia Advisors / Genetic Engineering & Biotechnology News). Yet, while researchers are gaining valuable knowledge from the massive amounts of data produced by NGS, they generally lack the information management technology to manage and analyze that data. In a recent survey by J.P. Morgan, 63 percent of NGS laboratory directors surveyed said that data storage, data management and informatics are the biggest hurdles to expanding next-generation sequencing.

The GenoLogics Geneus LIMS is designed specifically for genomics and NGS and allows researchers to automate workflows and easily trace samples and projects across multiple instruments and applications within one centralized system.

Advertisement